Scientists probe MS Drug's hidden powers
NCT ID NCT04821596
Summary
This study aimed to understand exactly how the drug cladribine works in people with multiple sclerosis (MS). Researchers tested blood cells from 77 MS patients and healthy donors in the lab to see how the drug affects the immune system and whether it might protect nerve cells. The goal was to gather evidence to support using cladribine for more advanced stages of the disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Rouen University Hospital
Rouen, 760031, France
Conditions
Explore the condition pages connected to this study.